Upharmacia May 2017 | Page 7

Upharmacia May 2017 and informational capabilities of the IPMA to prepare for entering the Ukrainian market through obtaining from the IPMA objective information about market opportunities, regulatory features and other data.” Pharmexcil is coordinated by representatives of the biggest pharmaceutical companies in India – Dr. Reddy's Laboratories, Sun Pharma, Ranbaxy, Aurobindo Pharma, etc. Moreover, officials of the Indian government also included in the administrative committee. N ovalik -P harm E xports its F ood S upplement to A ustria Ukrainian company Novalik-Pharm started exporting its food supplement Sitoprostat® for maintaining healthy urogenital system in men. The preparation was developed and produced by Novalik-Pharm. The main component of the food supplement (beta-Sitosterol) prevents the development of prostate adenoma. Austria is the first non-CIS market to be entered by the company. The supply contract was signed with local company OKOPHARM. “Considering that Austria has its own culture of consuming food supplement, while the legislation strictly controls their quality and safety, we consider the export to this country as the recognition of the high quality of our product,” the Head of Novalik-Pharm stated. Novalik-Pharm was founded in 2013. It produces medicines, food supplements, cosmetic and hygiene products. The company’s portfolio includes 13 products. B iofarma E nters I ndian M arket Biofarma registered two preparations of donor blood plasma in India. According to the Exports Director of the company, Biofarma received the first order on the shipment to India of 60 ths bottles of Albumin and 20 ths bottles of Bioven Mono. The company exports its products to CIS countries as well as to Mongolia, Yemen, Republic of Korea, Egypt, Mexico and Australia. Biofarma exports about 32.5% of its products. The company plans to open the new plant for blood fractionation to process up to 320 tons of blood plasma per year. REGULATORY UPDATES M inistry of H ealth H as O ffered F ull U se of O ld P rescriptions On May 23th, 2017 the Ministry of Health of Ukraine published draft “On Amendments to Order of the Ministry of Health of Ukraine No. 360 as of July 19th, 2005” for public discussion. The draft provides for use of prescription form number 1 (FA-1) of old pattern until its exhaustion. Forms number 1 are provided to www.upharma-c.com patients in pharmacies to receive medicines under reimbursement program. Let us remind you that the Ministry of Health of Ukraine has recently made changes to the Regulations on Prescribing Medicinal Products and Medical Devices, the Procedure for Sale of Medicinal Products and Medical Devices in Pharmacies and their Units and the Rules on Storage, Recording and Disposal of Prescription Forms approved by the mentioned order of the Provided by Ministry of Health No. 360. Based on current regulations the Ministry of Health of Ukraine allowed parallel use of forms No. 1 of old and new pattern by July 1st, 2017. If old forms are used, the prescription should contain the following information: — — corner stamp of healthcare institution; 7